Sarah A. Mullen

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

University of Nebraska Medical Center(Current)

Sarah A. Mullen is an author at University of Nebraska Medical Center specializing in receptor tyrosine kinase oncogenes, melanoma pharmacotherapy, and therapeutic resistance.

ORCID

Publications per year

2019–2024

Publications

Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human Melanoma

Charlotte R. Feddersen, Afshin Varzavand, Hayley R. Vaughn et al. · Cancer Research · 2019 · 22 citations

Medicine, Genetics, Oncology +17

DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell development

Alexandra H. Mandarano, Tarsha Harris, Blaine Creasy et al. · Cell Reports · 2023 · 12 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Systematic Review of Intralesional Therapies for Cutaneous Warts

Sarah A. Mullen, Emma L. Myers, Rebecca L. Brenner et al. · JID Innovations · 2024 · 12 citations · Full text

Veterinary Medicine, Dermatology, Immunology +17

1–3 of 3